Initially, the alliance will focus on advanced diagnostic tumor profiling in cancer treatment. The program will then expand into other areas such as cancer and cardiovascular risk as well as pharmacogenomics. Additionally, the alliance will create a database for clinical cancer data.
Through the alliance, Dignity Health and CHI will partner with laboratories and bioinformatics companies to develop individual-specific molecular tests for patients. The Precision Medicine Alliance is also aligned with the national Precision Medicine Initiative, a $215 million investment from the White House.
“The Precision Medicine Alliance will provide community physicians with access to a wide range of diagnostic technology that is currently only available in academic medical centers. This will provide more accurate diagnoses, with personalized therapies tailored to each patient through community providers, where the vast majority of care happens,” said Lloyd Dean, president and CEO of Dignity Health, in a statement.
Serving approximately 12 million patients annually, the alliance creates the largest community-based precision medicine program in the country.
More articles on health IT:
HealthShare Exchange inks tighter contract with members
How Mercy created a $54M virtual hospital in St. Louis
Opinion: How network surveillance can stop hospital hackers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.